Protein supplement use and prevalence of microalbuminuria in gym members.


Journal

The Journal of sports medicine and physical fitness
ISSN: 1827-1928
Titre abrégé: J Sports Med Phys Fitness
Pays: Italy
ID NLM: 0376337

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 27 6 2019
medline: 31 3 2020
entrez: 27 6 2019
Statut: ppublish

Résumé

Protein supplement use is common in bodybuilders because protein supplements are thought to increase muscle mass by preventing protein catabolism during exercise routines. Information on the consequences of protein supplement use is scarce and contradictory. Therefore, the identification of a kidney damage marker, such as microalbuminuria, could be transcendent in preventing probable organ compromise in healthy persons. The aim of this study is to determine the presence of microalbuminuria in gym members and whether there is an associated risk with protein supplement use. An analytic, descriptive, cross-sectional study was conducted. It included gym members whose clinical and nutritional histories were taken, identifying protein supplement use. Microalbuminuria was then determined through a random urine sample. Descriptive and inferential statistics were used for the data analysis. The objective was to determine the presence of microalbuminuria in gym members and whether there is an associated risk with protein supplement use. A total of 107 gym members, 71 men and 36 women, that met the inclusion criteria of the study were analyzed. Their mean age was 35±13 years, and the prevalence of microalbuminuria was 9.34%. There was active protein supplement use in 58% of the study participants, with a mean consumption duration of 16±22 months. No association with the presence of microalbuminuria was found (P=0.35). The prevalence of microalbuminuria in gym members was higher than that of the general healthy population and was not associated with protein supplement use.

Sections du résumé

BACKGROUND BACKGROUND
Protein supplement use is common in bodybuilders because protein supplements are thought to increase muscle mass by preventing protein catabolism during exercise routines. Information on the consequences of protein supplement use is scarce and contradictory. Therefore, the identification of a kidney damage marker, such as microalbuminuria, could be transcendent in preventing probable organ compromise in healthy persons. The aim of this study is to determine the presence of microalbuminuria in gym members and whether there is an associated risk with protein supplement use.
METHODS METHODS
An analytic, descriptive, cross-sectional study was conducted. It included gym members whose clinical and nutritional histories were taken, identifying protein supplement use. Microalbuminuria was then determined through a random urine sample. Descriptive and inferential statistics were used for the data analysis. The objective was to determine the presence of microalbuminuria in gym members and whether there is an associated risk with protein supplement use.
RESULTS RESULTS
A total of 107 gym members, 71 men and 36 women, that met the inclusion criteria of the study were analyzed. Their mean age was 35±13 years, and the prevalence of microalbuminuria was 9.34%. There was active protein supplement use in 58% of the study participants, with a mean consumption duration of 16±22 months. No association with the presence of microalbuminuria was found (P=0.35).
CONCLUSIONS CONCLUSIONS
The prevalence of microalbuminuria in gym members was higher than that of the general healthy population and was not associated with protein supplement use.

Identifiants

pubmed: 31240901
pii: S0022-4707.19.09794-9
doi: 10.23736/S0022-4707.19.09794-9
doi:

Substances chimiques

Phytosterols 0
Proteins 0
dietary supplement, SPORT 0
Diosgenin K49P2K8WLX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2053-2057

Auteurs

Héctor Parra-Lomelí (H)

School of Medicine, Universidad de Colima, Colima, Mexico.

Benjamín Trujillo-Hernández (B)

School of Medicine, Universidad de Colima, Colima, Mexico.

Francisco Espinoza-Gómez (F)

School of Medicine, Universidad de Colima, Colima, Mexico.

Paulina Vargas-Aguirre (P)

School of Medicine, Universidad de Colima, Colima, Mexico.

Abraham Orozco-Martinez (A)

Unit of Clinical Epidemiologic Research, Zone 1 General Hospital, Mexican Social Security Institute, Colima, Mexico.

Alicia M Negrete-Cruz (AM)

Unit of Clinical Epidemiologic Research, Zone 1 General Hospital, Mexican Social Security Institute, Colima, Mexico.

José Guzmán-Esquivel (J)

Unit of Clinical Epidemiologic Research, Zone 1 General Hospital, Mexican Social Security Institute, Colima, Mexico - pepeguzman_esquivel@outlook.com.

Iván Delgado-Enciso (I)

School of Medicine, Universidad de Colima, Colima, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH